Worse outcomes and guideline-driven care: Reply

Archives of Neurology

Volumn 67, Issue 11, 2010, Pages 1414-

  Prabhakaran, Shyam ^a   Chong, Ji Y ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

BLEEDING; BLOOD CLOT LYSIS; EMBOLISM; EVIDENCE BASED PRACTICE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE;

EID: 78149485221     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.288     Document Type: Note

References (1)

1. O'Donnell M, Oczkowski W, Fang J, et al; Investigators of the Registry of the Canadian Stroke Network. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol. 2006;5(9):749-754.